MeCP2: The chromatin connection and beyond

Biochemistry and Cell Biology

Volumn 83, Issue 3, 2005, Pages 251-262

  Zlatanova, Jordanka ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

Cancer; Chromatin modification; MeCP2; Methyl CpG binding proteins; Rett syndrome; Transcription repression

Indexed keywords

CARCINOGENS; DISEASES; DNA; INFORMATION ANALYSIS; METHANATION; MODIFICATION; MOLECULAR BIOLOGY; MUTAGENESIS; NEUROLOGY; PATIENT MONITORING; TUMORS;

CHROMATIN MODIFICATION; MECP2; METHYL-CGP-BINDING PROTEINS; RETT SYNDROME; TRANSCRIPTIONAL REPRESSION;

PROTEINS;

BRAIN DERIVED NEUROTROPHIC FACTOR; DEOXYRIBONUCLEASE I; DNA BASE; METHYL CPG BINDING PROTEIN 2;

BREAST TUMOR; CELL VIABILITY; CELLULAR DISTRIBUTION; CPG ISLAND; DNA BINDING; DNA FOOTPRINTING; DNA METHYLATION; GENE DELETION; GENE MUTATION; GENE REPRESSION; GENE SILENCING; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; HUMAN; MISMATCH REPAIR; MOTOR DYSFUNCTION; NERVE CELL DIFFERENTIATION; NONHUMAN; ONCOGENE; OVARY TUMOR; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; RETT SYNDROME; SHORT SURVEY;

AMINO ACID SEQUENCE; ANIMALS; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; CPG ISLANDS; DNA; DNA METHYLATION; DNA-BINDING PROTEINS; EXONS; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MODELS, BIOLOGICAL; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BINDING; PROTEIN ISOFORMS; REPRESSOR PROTEINS; RETT SYNDROME; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 24744450189     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o05-048     Document Type: Short Survey

References (84)

1. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U., and Zoghbi, H.Y. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23: 185-188.
2. Anonymous. 2004. Novel form of MeCP2 protein discovered. RSR Flash, III(2): 13. [Available from http://www.rsrf.org/downloads/ newsletters/Fall2004. pdf, cited 20 Apr 2005].
3. Ariani, F., Mari, F., Pescucci, C., Longo, I., Bruttini, M., Meloni, I., Hayek, G., Rocchi, R., Zappella, M., and Renieri, A. 2004. Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: report of one case of MECP2 deletion and one case of MECP2 duplication. Hum. Mutat. 24: 172-177.
4. Ausio, J., and Abbott, D.W. 2004. The role of histone variability in chromatin stability and folding. In Chromatin structure and dynamics: state-of-the-art. Edited by J. Zlatanova and S.H. Leuba. Elsevier. pp. 241-290.
5. Ballestar, E., and Wolffe, A.P. 2001. Methyl-CpG-binding proteins. Targeting specific gene repression. Eur. J. Biochem. 268: 1-6.
6. Ballestar, E., Yusufzai, T.M., and Wolffe, A.P. 2000. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry, 39: 7100-7106.
7. Ballestar, E., Paz, M.F., Valle, L., Wei, S., Fraga, M.F., Espada, J. et al. 2003. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J. 22: 6335-6345.
8. Ballestar, E., Ropero, S., Alaminos, M., Armstrong, J., Setien, F., Agrelo, R. et al. 2005. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients. Hum. Genet. 116: 91-104.
9. Bird, A.P. 1986. CpG-rich islands and the function of DNA methylation. Nature (London), 321: 209-213.
10. Bird, A.P., and Wolffe, A.P. 1999. Methylation-induced repression-belts, braces, and chromatin. Cell, 99: 451-454.
11. Bowen, N.J., Palmer, M.B., and Wade, P.A. 2004. Chromosomal regulation by MeCP2: structural and enzymatic considerations. Cell Mol. Life Sci. 61: 2163-2167.
12. Buschdorf, J.P., and Strätling, W.H. 2004. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. J. Mol. Med. 82: 135-143.
13. Caiafa, P., and Zampieri, M. 2005. DNA methylation and chromatin: the puzzling CpG islands. J. Cell. Biochem. 94: 257-265.
14. Carro, S., Bergo, A., Mengoni, M., Bachi, A., Badaracco, G., Kilstrup-Nielsen, C., and Landsberger, N. 2004. A novel protein, Xenopus p20, influences the stability of MeCP2 through direct interaction. J. Biol. Chem. 279: 25623-25631.
15. Cassel, S., Revel, M.-O., Kelche, C., and Zwiller, J. 2004. Expression of the methyl-CpG-binding protein MeCP2 in rat brain. An ontogenetic study. Neurobiol. Dis. 15: 206-211.
16. Chae, J.H., Hwang, H., Hwang, Y.S., Cheong, H.J., and Kim, K.J. 2004. Influence of MECP2 gene mutation and X-chromosome inactivation on the Rett syndrome phenotype. J. Child Neurol. 19: 503-508.
17. Chandler, S.P., Guschin, D., Landsberger, N., and Wolffe, A.P. 1999. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry, 38: 7008-7018.
18. Chen, R.Z., Akbarian, S., Tudor, M., and Jaenisch, R. 2001. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 27: 327-331.
19. Chen, W.G., Chang, Q., Lin, Y., Meissner, A., West, A.E., Griffith, E.G. et al. 2003. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (Wash.), 302: 885-889.
20. Cohen, D.R., Matarazzo, V., Palmer, A.M., Tu, Y., Jeon, O.H., Pevsner, J., and Ronnett, G.V. 2003. Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol. Cell. Neurosci. 22: 417-429.
21. Colantuoni, C., Jeon, O.-H., Hyder, K., Chenchik, A., Khimani, A.H., Narayanan, V. et al. 2001. Gene expression profiling in postmortem Rett syndrome brain: differential gene expression and patient classification. Neurobiol. Dis. 8: 847-865.
22. Collins, A.L., Levenson, J.M., Vilaythong, A.P., Richman, R., Armstrong, D.L., Noebels, J.L. et al. 2004. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum. Mol. Genet. 13: 2679-2689.
23. Coy, J.F., Sedlacek, Z., Bachner, D., Delius, H., and Poustka, A. 1999. A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3′-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum. Mol. Genet. 8: 1253-1262.
24. Crispi, S., Sanzari, E., Monfregola, J., De Felice, N., Fimiani, G., Ambrosio, R., D'Urso, M., and Ursini, M.V. 2004. Characterization of the human STAT5A and STAT5B promoters: evidence of a positive and negative mechanism of transcriptional regulation. FEBS Lett. 562: 27-34.
25. Cross, S.H., Charlton, J.A., Nan, X., and Bird, A.P. 1994. Purification of CpG islands using a methylated DNA binding column. Nat. Genet. 6: 236-244.
26. Cusack, S.M., Rohn, T.T., Medeck, R.J., Irwin, K.M., Brown R.J., Mercer, L.M., and Oxford, J.T. 2004. Suppression of MeCP2β expression inhibits neurite extension in PC12 cells. Exp. Cell Res. 299: 442-453.
27. Drewell, R.A., Goddard, C.J., Thomas, J.O., and Surani, M.A. 2002. Methylation-dependent silencing at the H19 imprinting control region by MeCP2. Nucleic Acids Res. 30: 1139-1144.
28. El-Osta, A., Kantharidis, P., Zalcberg, J.R., and Wolffe, A.P. 2002. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol. Cell. Biol. 22: 1844-1857.
29. Esteller, M. 2002. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene, 21: 5427-5440.
30. Fournier, C., Goto, Y., Ballestar, E., Delaval, K., Hever, A.M., Esteller, M., and Feil, R. 2002. Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. EMBO J. 21: 6560-6570.
31. Fraga, M.F., Ballestar, E., Montoya, G., Taysavang, P., Wade, P.A., and Esteller, M. 2003. The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res. 31: 1765-1774.
32. Fuks, F., Kurd, P.J., Wolf, D., Nan, X., Bird, A.P., and Kouzarides, T. 2003. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278: 4035-4040.
33. Georgel, P.T., Horowitz-Scherer, R.A., Adkins, N., Woodcock, C.J., Wade, P.A., and Hansen, J.C. 2003. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem. 278: 3281-32188.
34. Glaze, D.G. 2004. Rett syndrome: of girls and mice- lessons for regression in autism. Ment. Retard. Dev. Disabil. Res. Rev. 10: 154-158.
35. Gregory, R.I., Randall, T.E., Johnson, C.A., Khosla, S., Hatada, I., O'Neill, L.P. et al. 2001. DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpn and U2af1-rs1. Mol. Cell. Biol. 21: 5426-5436.
36. Guy, J., Hendrich, B., Holmes, M., Martin, J.E., and Bird, A. 2001. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 27: 322-326.
37. Hendrich, B., and Bird, A. 1998. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol. 18: 6538-6547.
38. Jones, P.L., Veenstra, G.J.C., Wade, P.A., Vermaak, D., Kass, S.U., Landsberger, N. et al. 1998. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19: 187-191.
39. Kaludov, N.K., and Wolffe, A.P. 2000. MeCP2 driven transcriptional repression in vitro: selectivity for methylated DNA, action at a distance and contacts with the basal transcription machinery. Nucleic Acids Res. 28: 1921-1928.
40. Kishi, N., and Macklis, J.D. 2004. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol. Cell. Neurosci. 27: 306-321.
41. Klose, R., and Bird, A. 2003. MeCP2 repression goes nonglobal. Science (Wash.), 302: 793-795.
42. Klose, R.J., and Bird, A.P. 2004. MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodeling complex. J. Biol. Chem. 279: 46490-46496.
43. Koch, C., and Strätling, W.H. 2004. DNA binding of methyl-CpG-binding protein MeCP2 in human MCF7 cells. Biochemistry, 43: 5011-5021.
44. Koizume, S., Tachibana, K., Sekiya, T., Hirohashi, S., and Shiraishi, M. 2002. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells. Nucleic Acids Res. 30: 4770-4780.
45. Kriaucionis, S., and Bird, A. 2003. DNA methylation and Rett syndrome. Hum. Mol. Genet. 12: R221-R227.
46. Kriaucionis, S., and Bird, A. 2004. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 32: 1818-1823.
47. Kudo, S. 1998. Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated. Mol. Cell. Biol. 18: 5492-5499.
48. Lewis, J.D., Meehan, R.R., Henzel, W.J., Maurer-Fogy, I., Jeppesen, P., Klein, F., and Bird, A.P. 1992. Purification, sequence and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69: 905-914.
49. Lorincz, M.C., Schübeler, D., and Groudine, M. 2001. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation. Mol. Cell. Biol. 21: 7913-7922.
50. Luikenhuis, S., Giacometti, E., Beard, C.F., and Jaenisch, R. 2004. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl. Acad. Sci. U.S.A. 101: 6033-6038.
51. Magdinier, F., and Wolffe, A.P. 2001. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl. Acad. Sci. U.S.A. 98: 4990-4995.
52. Magdinier, F., Billard, L.M., Wittmann, G., Frappart, L., Benchaib, M., Lenoir, G.M. et al. 2000. Regional methylation of the 5′ end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells. FASEB J. 14: 1585-1594.
53. Majumder, S., Ghoshal, K., Datta, J., Bai, S., Dong, X., Quan, N. et al. 2002. Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma. J. Biol. Chem. 277: 16048-16058.
54. Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y. et al. 2003. DNA methylation-related chromatin remodeling in activity-dependent Bdnf gene regulation. Science (Wash.), 302: 890-893.
55. Matarazzo, V., and Ronnett, G.V. 2004. Temporal and regional differences in the olfactory proteome as a consequence of MeCP2 deficiency. Proc. Natl. Acad. Sci. U.S.A. 101: 7763-7768.
56. Matarazzo, V., Cohen, D., Palmer, A.M., Simpson, P.J., Khokhar, B., Pan, S.-J., and Ronnett, G.V. 2004. The transcriptional repressor Mecp2 regulates terminal neuronal differentiation. Mol. Cell. Neurosci. 27: 44-58.
57. Meehan, R.R., Lewis, J.D., and Bird, A.P. 1992. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20: 5085-5092.
58. Miltenberger-Miltenyi, G., and Laccone, F. 2003. Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Hum. Mutat. 22: 107-115.
59. Mnatzakanian, G.N., Lohi, H., Munteanu, I., Alfred, S.E., Yamada, T., MacLeod, P.J.M. et al. 2004. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat. Genet. 36: 339-341.
60. Moretti, P., Bouwknecht, J.A., Teague, R., Paylor, R., and Zoghbi, H.Y. 2005. Abnormalities of social interactions and home cage behavior in a mouse model of Rett syndrome. Hum. Mol. Genet. 14: 205-220.
61. Nan, X., Tate, P., Li, E., and Bird, A. 1996. DNA methylation specifies chromosomal localization of MeCP2. Mol. Cell. Biol. 16: 414-421.
62. Nan, X., Campoy, F.J., and Bird, A. 1997. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88: 471-481.
63. Nan, X., Ng, H.-H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N., and Bird, A. 1998. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (London), 393: 386-389.
64. Neul, J.L., and Zoghbi, H.Y. 2004. Rett syndrome: a prototypical neurodevelopmental disorder. Neuroscientist, 10: 118-128.
65. Nguyen, C.T., Gonzales, F.A., and Jones, P.A. 2001. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res. 29: 4598-4606.
66. Ohki, I., Shimotake, N., Fujita, N., Nakao, M., and Shirakawa, M. 1999. Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1. EMBO J. 18: 6653-6661.
67. Ohki, I., Shimotake, N., Fujita, N., Jee, J.-G., Dcegami, T., Nakao, M., and Shirakawa, M. 2001. Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell, 105: 487-497.
68. Reichwald, K., Thiesen, J., Wiehe, T., Weitzel, J., Poustka, W.A., Rosenthal, A. et al. 2000. Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions. Mamm. Genome, 11: 182-190.
69. Shahbazian, M.D., Antalffy, B., Armstrong, D.L., and Zoghbi, H.Y. 2002. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 11: 115-124.
70. Shibayama, A., Cook, E.H., Jr., Feng, J., Glanzmann, C., Yan, J., Craddock, N. et al. 2004. MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Am. J. Med. Genet. 128B: 50-53.
71. Stancheva, I., Collins, A.L., Van den Veyver, I.B., Zoghbi, H., and Meehan, R.R. 2003. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by Notch in Xenopus embryos. Mol. Cell, 12: 425-435.
72. Stirzaker, C., Song, J.Z., Davidson, B., and Clark, S.J. 2004. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 64: 3871-3877.
73. Traynor, J., Agarwal, P., Lazzeroni, L., and Franke, U. 2002. Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MeCP2 mutations. BMC Med. Genet. 3: 12-26.
74. Tudor, M., Akbarian, S., Chen, R.Z., and Jaenisch, R. 2002. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl. Acad. Sci. U.S.A. 99: 15536-15541.
75. Valinluck, V., Tsai, H.-H., Rogstad, D.K., Burdzy, A., Bird, A., and Sowers, L.C. 2004. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 32: 4100-4108.
76. Vetter, M.L. 2003. Methylation gets SMRT: functional insights into Rett syndrome. Dev. Cell, 5: 359-360.
77. Wade, P.A. 2001a. Methyl CpG-binding proteins and transcriptional repression. BioEssays, 23: 1131-1137.
78. Wade, P.A. 2001b. Methyl-CpG binding proteins: coupling chromatin architecture to gene regulation. Oncogene, 20: 3166-3173.
79. Wakefield, R.I., Smith, B.O., Nan, X., Free, A., Soteriou, A., Uhrin, D. et al. 1999. The solution structure of the domain from MeCP2 that binds to methylated DNA. J. Mol. Biol. 291: 1055-1065.
80. Weitzel, J.M., Buhrmester, H., and Strätling, W.H. 1997. Chicken MAR-binding protein ARBP is homologous to rat methyl-CpG-binding protein MeCP2. Mol. Cell. Biol. 17: 5656-5666.
81. Young, J.I., and Zoghbi, H.Y. 2004. X-chromosome inactivation patterns are unbalanced and affect phenotypic outcome in a mouse model of Rett syndrome. Am. J. Hum. Genet. 74: 511-520.
82. Yusufzai, T.M., and Wolffe, A.P. 2000. Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res. 28: 4112-4119.
83. Zlatanova, J., Stancheva, I., and Caiafa, P. 2004. DNA methylation and chromatin structure. In Chromatin structure and dynamics: state-of-the-art. Edited by J. Zlatanova and S.H. Leuba. Elsevier. pp. 309-341.
84. Zoghbi, H.Y. 2003. Postnatal neurodevelopmental disorders: meeting at the synapse? Science (Wash.), 302: 826-830.